Alex Moloney
@amoloney.bsky.social
310 followers 800 following 16 posts
Back of the Napkin Host 🎙 Innovation Addict 💡 Chemical Biolgy and LNPs ⚗️ 🧫🧬 Product Manager - Small Molecules @ tocris/bio-techne Dad 👧 Ironman 🏊‍♂️🚵‍♂️🏃‍♂️ https://www.bio-techne.com/resources/podcasts/biotech-podcast-back-of-the-napkin
Posts Media Videos Starter Packs
Reposted by Alex Moloney
Reposted by Alex Moloney
doc-jlmeier.bsky.social
At his last celebration, he said something that stayed with me: "When you start, you think science is about the papers...then you realize it's about the people."
Reposted by Alex Moloney
lmoeckl.bsky.social
ÅNGSTRÖM-RESOLUTION IMAGING OF CELL-SURFACE GLYCANS🍬🍬🍬

For the first time, we are able to image the molecular architecture of the glycocalyx at Ångström resolution. A dream come true!

Read the preprint: biorxiv.org/content/10.110…

And find our tweetorial below#glycotimeme
amoloney.bsky.social
Your wish is my command. Licensed by Tocris and coming imminently!
Reposted by Alex Moloney
carolynbertozzi.bskyverified.social
Check it out! Another novel RNA modification - ADP-ribosylation - that was previously only known on proteins. A cousin to #glycoRNA 👏

www.nature.com/articles/s41...
Graphic showing modification of mRNA with ADP-ribose mediated by bacterial enzyme cmdTAC
amoloney.bsky.social
And collaborators! 😄
amoloney.bsky.social
Ow boy! Just when I thought I couldn't be impressed by a JQ1 containing compound anymore... it gets mashed with my favourite Janelia Fluor dye (JF635) and a halotag ligand. Exceptional work #chembio
dyechemist.bsky.social
🧵Prepint alert! Optimizing Multifunctional Fluorescent Ligands for Intracellular Labeling | tinyurl.com/3n55hvsc. With Jason Vevea, Ed Chapman, and @so-lets-kilab70.bsky.social, we combined dye chemistry, HaloTag, microscopy and cell biology to make protein purification and manipulation tools.
amoloney.bsky.social
Exceptional degrader ("targeted glue") development story. Tour de force 👏
andre-head.bsky.social
Really pleased to share this story from Amphista Therapeutics on the discovery and MoA of a potent and selective BRD9 "targeted glue" degrader. The compound also works in vivo and is orally bioavailable! Fantastic work from the team on a super fun project!
www.biorxiv.org/content/10.1...
Reposted by Alex Moloney
amoloney.bsky.social
Tough one! For me:
2000 Bertozzi Science Staudinger paper.
2008 Fox/Devaraj Tetrazine papers
2012 Chin/Fox JACS UAA incorporation.
Reposted by Alex Moloney
stephanhacker2.bsky.social
Interesting ChemRxiv preprint by the group of Andrey Klymchenko. They develop fluorescent probes that enrich in the membrane and then covalently label proteins. This leads to plasma membrane labeling, which is resistant to cell permeabilization. #ChemBio www.biorxiv.org/cont...
Lipid-directed covalent fluorescent labeling of plasma membranes for long-term imaging, barcoding and manipulation of cells
Fluorescent probes for cell plasma membrane (PM) are generally based on amphiphilic anchors that incorporate non-covalently into biomembranes. Therefore, they are not compatible with fixation and permeabilization, presence of serum, or cell co-culture because of their exchange with the medium. Here, we report a concept of lipid-directed covalent labeling of PM, which exploits transient binding to lipid membrane surface generating high local dye concentration, thus favoring covalent ligation to random proximal membrane proteins. This concept yielded a class of fluorescent probes for PM (MemGraft), where a cyanine dye (Cy3 and Cy5) bears at its two ends low-affinity membrane anchor and reactive group: an activated ester or a maleimide. We found that MemGraft probes with these reactive groups provide efficient PM labelling, in contrast to a series of control compounds, including commercial Cy3-based labels of amino and thiol groups, revealing the crucial role of the membrane anchor combined with high reactivity of activated ester and a maleimide groups. In contrast to conventional PM probes, based on non-covalent interactions, MemGraft labelling approach is compatible with cell fixation, permeabilization, trypsinization and presence of serum. The latter allows long-term cell tracking and video imaging of cell PM dynamics without signs of phototoxicity. The covalent strategy also enables staining and long-term tracking of co-cultured cells labelled in different colors without probes exchange. Moreover, combination of different ratios of MemGraft-Cy3 and MemGraft-Cy5 probes enabled long-term cell barcoding in at least 5 color codes, important for tracking and visualizing multiple cells populations. Ultimately, we found that MemGraft strategy enables efficient biotinylation of cell surface, opening the path to cell surface engineering and cell manipulation. ### Competing Interest Statement The authors have declared no competing interest.
www.biorxiv.org
amoloney.bsky.social
Amazing! Thanks Chris
amoloney.bsky.social
Really hope journals start to integrate bluesky 🦋 into altmetric soon! Any plans? @acspublications.bsky.social @cellpress.bsky.social
Reposted by Alex Moloney
amoloney.bsky.social
Me whizzing to the structures in this preprint 👀.
amoloney.bsky.social
Align on vision, differ on skill sets. Love this idea
Reposted by Alex Moloney
doc-jlmeier.bsky.social
The starter pack the TPD community has been waiting for:

go.bsky.app/CE2P2Yh
amoloney.bsky.social
I also know a podcast that's perfect for eureka moment stories @carolynbertozzi.bsky.social . Back of the Napkin would love to host you! #glycotime
Reposted by Alex Moloney
kwhitehead.bsky.social
Thanks to Alex for hosting me on Bio-techne's Back of the Napkin Podcast. We discuss my science, life as a scientist, what it's like to be a TED speaker, and how strong feelings of anger won me an NIH New Innovator Award. Hope it can be helpful if anyone needs some inspiration.
amoloney.bsky.social
First Napkin on Bluesky! 🦋 Drug delivery extrodinare and science communication master @kwhitehead.bsky.social on #BackoftheNapkin 🎙 Katie sure nows how to cook up an innovative idea! open.spotify.com/episode/7jVY...
Reposted by Alex Moloney